Andy Yasutake

Andy Yasutake is a San Francisco-based solo angel writing $25K to $100K at pre-seed and seed into AI/ML in healthcare and health IT software. The explicit AI focus combined with health IT is a sharp positioning signal: this is an investor who actively wants to see AI-driven healthcare software, particularly in workflow automation, clinical decision support, and ambient documentation. Public LinkedIn and Twitter presence suggest a publicly engaged investor reachable through warm channels and visible in the AI healthcare conversation. The Bay Area base provides access to West Coast healthcare investors, the dense AI engineering community, and the broader San Francisco health-tech ecosystem. Check size positions him as a single-conviction angel suited to syndicate participation rather than a round leader, with highest value to founders who want an AI-credentialed angel for technical advisory and downstream introductions to specialist AI healthcare seed funds. Founders most likely to fit are early AI healthcare software companies with strong technical teams, defensible model or data moats, and a clear provider or payer buyer. Biotech, devices, life sciences tools, and pure consumer wellness without an AI wedge are weaker matches. The entry path is a LinkedIn or Twitter message, preferably warmed by a mutual Bay Area AI or healthcare connection, leading with the AI moat, the data and clinical evidence plan, the buyer persona, and the specific reason an AI-focused angel at this profile materially accelerates the round and downstream Series A introductions in the AI healthcare investor community.